Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 289-300 of 1,740
Drug study icon
CompletedNCT06854601

Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Yekaterinburg
Why is this study shown?

This study is directly about ADHD.

ADHD, AnxietyDrugFrom 6 Years to 12 Years
Countries
Russia
Sponsor
Pharmasoft
Condition
ADHD, Anxiety
Drug study icon
CompletedNCT03327402

Safety study of SHP465 in ADHD

This study is completed in the United States. It is testing SHP465 for ADHD.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 4 Years to 5 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Drug study icon
WithdrawnNCT03546400

Safety study of Methylphenidate HCl ERCT in ADHD

This study was withdrawn. It is testing Methylphenidate HCl ERCT for ADHD.

Location not clearly listed
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 48 Months to 69 Months
Countries
Sponsor
Pfizer
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.